Introduction
Glycosylation was once considered a rare protein modification in bacteria. However, progress done in recent years has demonstrated that protein glycosylation is widely distributed among bacteria (Szymanski and Wren 2005) . Many different bacterial species are able to produce O-or N-glycoproteins by transferring a glycan previously assembled onto the lipid undecaprenylpyrophosphate (Und-PP). In N-glycosylation, the transfer of the glycan from the lipid to the Asn residues in acceptor proteins is carried out by a N-oligosaccharyltransferase (N-OTase) (Wacker et al. 2002) , whereas in the O-glycosylation systems that operate in bloc, an O-oligosaccharyltransferase (O-OTase) attaches the pre-assembled glycan to Ser or Thr residues (Aas et al. 2007; Faridmoayer et al. 2007) . Both N-OTases and O-OTases can be functionally expressed in Escherichia coli, and many of them have the ability to transfer a variety of polysaccharides to protein carriers in vivo (Feldman et al. 2005; Faridmoayer et al. 2008) . Thus, bacterial glycosylation systems constitute powerful toolboxes to be exploited for the generation of novel vaccines and therapeutics.
Campylobacter jejuni PglB (PglB Cj ) is the N-OTase responsible for the glycosylation of more than 40 proteins (Young et al. 2002) . PglB Cj is homologous to Stt3, the main component of the eukaryotic OTase complex (Wacker et al. 2002) . Kowarik et al. (2006a) have shown that, in contrast to the eukaryotic system in which glycosylation is mostly co-translocational, translocation of the acceptor proteins and their glycosylation can occur as independent processes when C. jejuni system is expressed in E. coli. It has been established that PglB Cj follows † At the time this study was submitted related findings were reported (Schwarz F, Lizak C, Fan Y, Fleurkens S, Kowarik M, Aebi M. 2010 . Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo. Glycobiology 21:45-54). The authors reported on the N-glycosylation machinery from the epsilon proteobacteria Campylobacter lari. In that study the oligosaccharyltranferase exhibited a relaxed specificity towards the acceptor site. However, unlike D. desulfuricans PglB, the C. lari enzyme conserved a predominant specificity for the primary sequence (D/E(-2)-X-N-X-S/T(+2)), which contained an acidic amino acid in the -2 position.
the "minus two rule" (Kowarik et al. 2006a ). This rule establishes that a negatively charged amino acid at position minus two from the acceptor Asn residue is required for glycosylation by bacterial N-OTases. This sequon, displayed in a flexible loop in the periplasm, is recognized and glycosylated by PglB Cj. Interestingly, addition of an Asp residue at the −2 position allowed the glycosylation of eukaryotic proteins by PglB Cj (Kowarik et al. 2006a ). It has been recently shown that one of the Helicobacter pullorum PglB homologs also follows this "minus two" rule (Jervis et al. 2010 ). This absolute requirement of a negatively charged amino acid at position −2 from the glycosylation site suggested a model in which this amino acid is part of the catalytic or recognition mechanism (Kowarik et al. 2006b ). Furthermore, it gives to the glycosylation process increased stringency and specificity, which in eukaryotes is generally accomplished by coordinating translation, translocation and glycosylation and by the presence of additional subunits that regulate Stt3 activity.
PglB homologous enzymes are also found in archaea and in many epsilon-proteobacteria, including pathogenic and environmental species (Yurist-Doutsch et al. 2008; Maita et al. 2010) . Outside the epsilon-proteobacteria, PglB homologs have only been identified in the Desulfovibrio genus, which belongs to the delta-proteobacteria (Szymanski and Wren 2005) . Desulfovibrio species are found in diverse environments, including soil, animal digestive tracts, and sea and fresh water. Desulfovibrio organisms are sulfate-reducing bacteria and have been involved in several processes, such as iron corrosion, bioremediation and inflammatory diseases (Hamilton 1998; Goldstein et al. 2003; Heidelberg et al. 2004) . At least one N-glycoprotein, the 16 heme cytochrome (HmcA), has been identified in D. gigas. Santos-Silva et al. (2007) proposed that a disaccharide composed of N-acetylglucosamine and its epimer N-acetylallosamine is attached to the Asn261 of HmcA. Intriguingly, the N-glycosylation site associated with this residue, T 259 AN 261 GT 263 , does not have a negatively charged amino acid in the −2 position with respect to the Asn. It has been suggested that the genes putatively involved in protein glycosylation in Desulfovibrio are not organized in a cluster as is the case in most of the epsilon-proteobacteria carrying a PglB homolog and are instead spread throughout the genome (Szymanski and Wren 2005) . In this study, we functionally expressed Desulfuricans desulfuricans PglB in E. coli. We demonstrate that D. desulfuricans PglB (PglB Dd ), which is more closely related to its eukaryotic and archaeal counterparts than to the Campylobacter enzymes, has OTase activity. Interestingly, unlike C. jejuni and H. pullorum homologs, PglB Dd preferentially glycosylates, a sequon that does not possess a negatively charged amino acid at the position −2, with respect to the glycosylation site. Furthermore, we show that PglB Dd is able to transfer mono-and polysaccharides in engineered E. coli strains.
Results
Functional expression of D. desulfuricans G20 PglB in E. coli Multiple sequence alignment of STT3, PglB Cj and their homologs across the three domains of life exhibited low sequence similarity, except in the vicinity of the highly conserved WWDxG motif that contains the proposed catalytic residues (Wacker et al. 2002) (Figure 1A ). In silico analysis showed the presence of STT3 orthologs among different Desulfovibrio spp. genomes. The phylogenetic analysis of the catalytic region revealed that Desulfovibrio PglB homologs are more closely related to the eukaryotic and archaeal OTases than to other bacterial N-OTases ( Figure 1B) .
All genes necessary for N-linked glycosylation in C. jejuni are located in a single locus (Wacker et al. 2002; Linton et al. 2005) . We found a similar arrangement in D. desulfuricans G20 where the PglB homolog appears to be part of a locus that includes an ABC transporter, three glycosyltransferases and enzymes involved in nucleotide sugar biosynthesis ( Figure 1C ). The putative activities of these genes have been suggested based on their homology with known components of other glycosylation systems and polysaccharide biosynthetic pathways and are presented in Supplementary data, Table SI .
To test its OTase activity, PglB Dd and its putative substrate HmcA from D. desulfuricans G20 were cloned and expressed in E. coli as described in Material and methods. The third component needed to reconstitute the N-glycosylation system is a lipid-linked oligosaccharide (LLO). Because other bacterial OTases have relaxed glycan specificity, we hypothesized that PglB Dd could transfer the C. jejuni heptasaccharide (GalNAc-α1,4-GalNAc-α1,4[Glc-β1,3]GalNAc-α1,4-GalNAc-α1,4-GalN Ac-α1,3-Bac2,4diNAcβ1) to HmcA. Two populations of C. jejuni LLO are synthesized in E. coli transformed with plasmid pACYC-pgl, which contains all the genes required for the synthesis of the C. jejuni heptasaccharide onto Und-PP. The two structures produced differ in the sugar incorporated at the reducing end of each glycan, which can be bacillosamine (2,4-diacetimido-2,4,6-trideoxyglycopyranose) or N-acetylglucosamine (Wacker et al. 2002; Reid et al. 2008) . Although both PglB Dd and HmcA were expressed in E. coli, no glycosylation was observed (Supplementary data, Fig. S1 ). Several factors may account for this result. The native HmcA proteins from D. gigas and D. vulgaris are high-molecular-weight cytochromes with 16 c-type haem groups covalently bound to the polypeptide (Santos-Silva et al. 2004) . The maturation of c-type cytochromes leading to the holoprotein occurs in the periplasm and requires the function of specific cytochrome c maturation genes (ccm) (Herbaud et al. 2000) . We detected recombinant HmcA protein in the periplasm, which indicated that E. coli was able to synthesize and export the polypeptide. We speculated that lack of glycosylation could be attributed to an improper attachment of the haem groups to the apoprotein. However, glycosylation was not observed even in presence of the ccm genes (not shown). These results prompted us to change the protein target HmcA for a well-characterized N-linked glycoprotein, C. jejuni AcrA. As previously shown, expression of the AcrA gene in E. coli strain CLM24 along with a functional C. jejuni N-linked protein glycosylation locus, which includes PglB Cj , produced three bands corresponding to non-, monoand di-glycosylated AcrA ( Figure 2A , lane 1) (Wacker et al. 2002) . To test PglB Dd activity, a version of the C. jejuni N-linked glycosylation locus with an inactivated pglB gene ( pACYCpglBmut) was co-expressed along with AcrA and N-glycosylation in delta-proteobacteria PglB Dd . Only one additional band of decreased mobility, compatible with the mono-glycosylated form of AcrA, was observed in periplasmic extracts analyzed by western blot ( Figure 2A , lane 4). This result suggested that D. desulfuricans PglB has oligosaccharyltransferase activity. However, in contrast to PglB Cj , only one of the available N-glycosylation sites in the target protein was recognized by PglB Dd . To test whether additional bands corresponding to AcrA glycosylated at multiple sites could be detected, AcrA was purified by affinity chromatography and analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and western blot ( Figure 2B ). As with the periplasmic extracts, only two bands were detected with anti-AcrA antibodies. The upper band was also reactive toward sera specific for the C. jejuni heptasaccharide. These results indicated that only one glycosylation site on AcrA was occupied due to the activity of PglB Dd . Predicted open reading frames (ORFs) are indicated by arrows with colors coded according to the predicted function: ABC transporter, orange; regulatory proteins, light blue; glycosyltransferases, green; enzymes involved in sugar biosynthesis, blue; STT3 homolog, red; sugar-modifying enzymes, yellow. The predicted function and homology of each ORF is summarized in Supplementary data, Table SI .
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N-glycosylation site recognized by PglB Dd maps within the sequence NNST The crystal structure of D. gigas HmcA suggested that the protein is glycosylated at N 261 . Surprisingly, the N-glycosylation site associated with this residue, T 259 AN 261 GT 263 , does not have a negatively charged amino acid in the −2 position related to the Asn. This condition was proposed to be a strict requisite for glycosylation by bacterial oligosaccharyltransferases (Kowarik et al. 2006b ). AcrA contains five potential N-glycosylation sites N-X-S/T, but only the two that have an Asp residue at the −2 position have been shown to be recognized by the C. jejuni enzyme (N123 and N273) ( Figure 3A ) (Nita-Lazar et al. 2005) .
To identify which of the hypothetical N-glycosylation sites in AcrA was recognized by PglB Dd , we analyzed the glycosylation status of mutants where each of the five relevant Asn residues were mutated to Gln. Unexpectedly, substitutions in either N273 or N274 abolished glycosylation ( Figure 3B , lanes 5 and 6). Mutagenesis of the three remaining Asn residues did not affect glycosylation. This experiment suggested that the glycosylation requirements of PglB Dd and PglB Cj are different, because substitution of N274 to Gln did not abolish glycosylation by the C. jejuni OTase.
Matrix-assisted laser desorption-ionisation mass spectrometry (MALDI-MS) analysis of tryptic peptides from the purified glycosylated AcrA identified a peak of m/z 4161 in the high mass region of the spectrum. This mass corresponds to the 268 AVFDNNNSTLLPGAFATITSEGFIQK 294 peptide modified with the C. jejuni heptasaccharide of 1406 Da. Tandem MS/MS analysis of this peak produced a fragmentation series consistent with the known C. jejuni heptasaccharide structure (Figure 4) . Interestingly, only the glycan with bacillosamine at the reducing end was detected. This data supported the results of the site-directed mutagenesis and established that the glycosylation site is contained in the 268 AVFDNNNSTLLPGAFA TITSEGFIQK 294 peptide. However, due to the proximity of the two candidate Asn residues, MS analysis did not allow the exact determination of the glycosylation site.
PglB Dd does not require a negatively charged residue in the −2 position of the glycosylation sequon N-X-S/T Two different overlapping sequons, DNN 273 NS and NNN 274 ST, are present in the glycopeptide identified by MS AcrA mutants and C. jejuni LLO were resolved by SDS-PAGE and examined by western inmunoblot. Detection was performed with antiserum against recombinant AcrA. Samples were loaded as follows: lane 1, CLM24/pIH18, pACYCpglB mut and pEXT20; lane 2, CLM24/pMVI16, pACYCpglB mut and pMVI8; lane 3, CLM24/pMVI17, pACYCpglB mut and pMVI8; lane 4, CLM24/pMVI18, pACYCpglB mut and pMVI8; lane 5, CLM24/pMVI20, pACYCpglB mut and pMVI8; lane 6, CLM24/pMVI21, pACYCpglB mut and pMVI8; lane 7, CLM24/pIH18, pACYCpglB mut and pMVI8.
N-glycosylation in delta-proteobacteria analysis. To unequivocally determine the Asn residue carrying the heptasaccharide, we tested glycosylation of mutants in which the remaining possible glycosylation determinants of each sequon, D271 and S275 (site #1) and T276 (site#2), were substituted to Ala ( Figure 5A ). Glycosylation of these variants by PglB Dd was only abolished in the T276A mutant ( Figure 5B , lane 4), indicating that N 274 ST is the sequence recognized by PglB Dd . These results showed that D. desulfuricans OTase recognizes the same short consensus sequence N-X-S/T as the eukaryotic OTase complex. In contrast to C. jejuni PglB, D. desulfuricans OTase does not require a negatively charged residue at the −2 or −3 positions in the sequon.
PglB Dd can transfer mono-and polysaccharides It was previously shown that C. jejuni PglB presents relaxed oligosaccharide substrate specificity, which is demonstrated by its ability to transfer different glycans ranging from oligo-to polysaccharides with diverse composition and structure (Feldman et al. 2005; Wacker et al. 2006 ). In the previous experiments, we demonstrated that PglB Dd can transfer the C. jejuni heptasaccharide, which contains bacillosamine at the reducing end. This oligosaccharide is likely different from the native D. desulfuricans glycans, suggesting a relaxed glycan specificity also for PglB Dd . To characterize PglB Dd glycan requirements, we tested whether PglB Dd is able to transfer a single monosaccharide to AcrA. PglB Dd and AcrA were expressed in E. coli CLM24 together with a plasmid carrying the Neisseria gonorrhoea pglFBCD genes, required for the Sequence of the glycosylation sites identified by MS/MS. The numbered residues were changed to Ala by site-directed mutagenesis. (B) Periplasmic extracts of E. coli strain CLM24 expressing PglB Dd , C. jejuni LLO and AcrA mutants D271A, S275A or T276A were resolved by SDS-PAGE and examined by western inmunoblot. Detection was performed with antiserum against recombinant AcrA. Samples were loaded as follow: lane 1, CLM24/ pIH18, pACYCpglB mut and pEXT20; lane 2, CLM24/pIH18, pACYCpglB mut and pMVI8; lane 3, CLM24/pMVI29, pACYCpglB mut and pMVI8; lane 4, CLM24/pMVI31, pACYCpglB mut and pMVI8; lane 5, CLM24/pMVI30, pACYCpglB mut and pMVI8.
synthesis of lipid-linked 2,4-diacetamido-2,4,6-trideoxyhexose (DATDH; Borud et al. 2010 ). Whole-cell extracts were resolved by SDS-PAGE and examined by western blot. Glycosylated AcrA was detected by antibodies against DATDH only when PglB Dd was expressed ( Figure 6A , lower panel, lane 2). Due to the addition of only one sugar, no shift in the molecular weight of AcrA was observed when examined with anti-AcrA antiserum ( Figure 6A, upper panel) .
To further characterize D. desulfuricans OTase, we introduced the gene cluster necessary for the synthesis of E. coli O7 O-antigen in CLM24 strain co-expressing PglB Dd and AcrA. Purified AcrA was analyzed by SDS-PAGE and western blot. A ladder of bands of high molecular weight (around 60 kDa) was detected by a rhamnose-binding lectin (SLT3) that recognized the O7 polysaccharide when PglB Dd was present (Figure 6 , lane 5), suggesting that they correspond to modified AcrA. However, this ladder was not detected by anti-AcrA ( Figure 6 , lane 2), which indicated that the level of glycosylation was very low compared with the level achieved by PglB Cj (Figure 6, lanes 3 and 6) .
Discussion
The discovery of the C. jejuni N-glycosylation system revealed that bacteria can also N-glycosylate proteins. PglB Cj is a very versatile enzyme, which, unlike most of its eukaryotic counterparts, is sufficient for glycosylation and it is able to use a large repertoire of glycan substrates (Feldman et al. 2005; Wacker et al. 2006) . Only 28 bacterial sequences are listed as oligosaccharyltransferases at the CAZy database (glycosyltransferase family GT66) from which 10 belong to the delta-proteobacteria subdivision (Desulfovibrionales and Desulfuromonadales) and the rest to the epsilonproteobacteria subdivision (mainly Campylobacterales). Besides PglB Cj , only PglB from H. pullorum (PglB Hp ) has been functionally characterized. Although in H. pullorum the native glycan is different to the C. jejuni heptasaccharide, PglB Hp follows the "minus two rule" previously established for PglB Cj (Kowarik et al. 2006b; Jervis et al. 2010) . In this work, we functionally characterized D. desulfuricans PglB, the first OTase from a delta-proteobacterium that has been studied. Combining site-directed mutagenesis and MS techniques, we showed that PglB Dd can glycosylate a C. jejuni protein at a single site, N274. The same protein is diglycosylated by PglB Cj at two different sites, N123 and N273. These two sites contain an Asp residue at position −2. Surprisingly, even though these two canonical N-glycosylation sites were intact and available for glycosylation, PglB Dd preferred the N274 site, which had no negatively charged amino acid located at position −2 (N272). Substitution of the Asp residue located at position −3 relative to the glycosylation site by Ala (D271A) did not affect glycosylation. Interestingly, substitution of the Asn residue at position −1 by Gln (N273Q) resulted in unglycosylated AcrA. These results are in agreement with the observation that the glycosylation site reported for D. gigas HmcA does not follow the "minus two rule" (Santos-Silva et al. 2007 ) and demonstrates that PglB Dd recognizes its acceptor sequence differently than its epsilonproteobacteria counterparts.
PglB Dd was not able to glycosylate D. gigas HmcA protein in E. coli. Although this result can have different explanations, it is tempting to speculate that even within the genus Desulfovibrio, PglB Dd and PglB Dg may recognize different acceptor sequons. To date, HmcA is the only Desulfovibrio glycoprotein identified (Santos-Silva et al. 2007 ). Furthermore, the structures of the endogenous Desulfovibrio glycans have yet to be unequivocally determined. We have found that PglB Dd is encoded in a locus that may also encode enzymes for the synthesis of a complex glycan, and it is unlikely to produce a simple disaccharide like the one suggested to be synthesized in D. gigas.
We have found that in addition to the endogenous glycan in D. desulfuricans and the C. jejuni heptasaccharide, PglB Dd can efficiently transfer a single N,N′-diacetyl-bacillosamine (Bac) Fig. 6 . PglB Dd can transfer mono-and polysaccharides to AcrA. (A) Whole-cell extracts of E. coli CLM24 strain expressing PglB Dd , AcrA and N. gonorrhoea DATDH were resolved by SDS-PAGE and examined by western inmunoblot. Detection was performed with antiserum against recombinant AcrA produced in E. coli (upper panel) and N. gonorrhoea antiserum UOS-2 (against DATDH, lower panel). One band corresponding to glycosylated AcrA was observed only in the presence of PglB Dd (lane 2). Samples were loaded as follow: lane 1, CLM24/pIH18 (expressing AcrA), pEF33 ( pglFBCD) and pEXT20; lane 2, CLM24/pIH18, pEF33 and pMVI8 (expressing Dde3699). (B) AcrA was purified from E. coli strain CLM24 expressing PglB Dd and E. coli O7 antigen. Samples were resolved by SDS-PAGE and examined by western inmunoblot. Detection was performed with antiserum against recombinant AcrA (right panel) and a rhamnose-binding lectin (SLT3) against the O7 polysaccharide (left panel) (Tateno et al. 1998 ). Samples were loaded as follows: lanes 1 and 4, CLM24/pIH18, pJHCV32 and pEXT20; lanes 2 and 5, CLM24/pIH18, pJHCV32 and pMVI8; lanes 3 and 6, CLM24/pIH18, pJHCV32 and pMAF10.
N-glycosylation in delta-proteobacteria residue to AcrA. Linton et al. (2005) found that PglB Cj was able to transfer a single Bac residue to a C. jejuni protein. In contrast, Glover et al. (2005) have demonstrated that, in vitro, the minimal glycan donor for PglB Cj is an Und-PP-bound disaccharide, GalNAc-α3-Bac-PP-Und. Moreover, in recent in vivo AcrA glycosylation experiments in E. coli SCM3, it was only possible to obtain a monosaccharide bound to AcrA via transfer of the full C. jejuni heptasaccharide and subsequent enzymatic trimming of the sugars (Schwarz et al. 2010 ). Thus, whether PglB Cj is able to efficiently transfer a monosaccharide remains a matter of contention. We also demonstrated that like PglB Cj , PglB Dd is able to transfer polysaccharides to proteins. However, it must be acknowledged that PglB Dd was less efficient in transferring the E. coli O7 antigen to AcrA compared with PglB Cj (Figure 6 ). Furthermore, we failed to detect transfer of other polysaccharides, such as the Pseudomonas aeruginosa O11 and E. coli O16 antigens to AcrA under the same experimental conditions in which PglB Cj efficiently transferred the polysaccharide (data not shown). Thus, PglB Dd may have more stringent glycan specificity than PglB Cj , preferring short over long glycan chains. Further work will be necessary to elucidate how PglB Dd recognizes its substrates, which is still not well understood for the eukaryotic OTases (Imperiali and Hendrickson 1995; Schulz et al. 2009 ).
The discovery of bacterial glycosylation systems has generated an opportunity for the manipulation of their components to engineer novel glycan-containing structures that may be used as conjugate vaccines and/or therapeutics. Our findings indicate that bacterial N-OTases may have diverse properties, including different acceptor sequences and glycan specificities. Novel OTases with distinct properties are necessary to broaden the spectrum of possible glycoengineering strategies (Langdon et al. 2009 ).
Material and methods/experimental procedures Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed in Table I . E. coli strains were grown in Luria Bertani broth/ agar at 37°C. Antibiotics ampicillin (Ap) 100 µg/mL, spectinomycin (Sp) 40 µg/mL, chloramphenicol (Cm) 10 µg/mL, kanamycin (Km) 50 µg/mL and tetracycline (Tc) 5 µg/mL were added for selection as needed.
Construction of plasmids
Dde3699 gene ( pglB Dd ) was amplified by polymerase chain reaction (PCR) with oligonucleotides PglB Dd XbaI (5′-AATT TCTAGAATGACCATCCTTCACGTCTCC-3′) and PglB Dd HindIII-7HIS (5′-AATTAAGCTTCTAGTGGTGGTGGTG GT GGTGGTGCAGCACTTCGTACACCTTGGTCTTGC-3′) using Pfu polymerase and D. desulfuricans G20 genomic DNA as template. The PCR product was digested with XbaI and HindIII and cloned into pEXT20 (Dykxhoorn et al. 1996) cut with the same enzymes. The resulting plasmid, pMVI8, was confirmed by sequencing. Isopropyl-beta-D-thiogalactopyranoside (IPTH)-dependent expression of PglB Dd with hepta-His tag was confirmed by western blot. Dde0653 gene (hmcA) was amplified by PCR with oligonucleotides HmcA XbaI (5′-AATTTCTAGAATGCGTTTCA CCATTTTTCAAAGGACTG-3′) and HmcA HindIII-7HIS (5′-AATTAAGCTTCTAGTGGTGGTGGTGGTGGTGGTGC AGATCGCGTTTTTTGTGACACTC-3′) using Pfu polymerase and D. desulfuricans G20 genomic DNA as template. The PCR product was digested with XbaI and HindIII and cloned into pMLBAD cut with the same enzymes. The resulting plasmid, pMVI15, was confirmed by sequencing. Arabinosedependent expression of HmcA with hepta-His tag was confirmed by western blot.
For the expression of AcrA variants/mutants, a 912 bp PsiIXhoI fragment from plasmids pET24(AcrA-Asn1), pET24 (AcrA-Asn2), pET24(AcrA-Asn3), pET24(AcrA-Asn4.1) and pET24(AcrA-Asn4.2) was cloned into pIH18 cut with the same enzymes. The resulting plasmids pMVI16, pMVI17, pMVI18, pMVI20 and pMVI21 encode for periplasmic/soluble form of AcrA with the point mutations N117L, N123L, N147L, N273L or N274L, respectively. Point mutations D271A, S275A and T276A were introduced by QuickChange site-directed mutagenesis (Stratagene, La Jolla, CA) into plasmid pWA2 and subcloned into pIH18 using PsiI and XhoI resulting in plasmids pMVI29, pMVI30 and pMVI31. All vectors were confirmed by restriction analysis and sequencing.
Protein expression and purification of glycosylated AcrA E. coli CLM24 expressing AcrA, PglB Dd and a plasmid coding for the synthesis of undecaprenol-linked sugars were grown at 37°C to an OD 600 of 0.6 and induced by the addition of IPTG (0.1 mM) or L-arabinose (0.2%, w/v) as needed. Cells were harvested by centrifugation after a 20 h induction, and periplasmic extracts were prepared by lysozyme treatment as described elsewhere (Feldman et al. 2005) . The periplasmic fraction was subjected to a Ni 2+ affinity chromatography (NTA agarose, Qiagen) and analyzed by inmunoblot and mass spectrometry.
Western blot analysis
Protein expression and glycosylation were analyzed by SDS-PAGE on 10% gels. The gels were electroblotted onto nitrocellulose membrane that were single-or double-probed with antibodies against the protein acceptor and the glycan moiety as specified in each experiment. Anti-rabbit and anti-mouse IgG-HRP (Rockland) or IRDye-labeled secondary antibodies (LI-COR, 1:10,000) were used on membranes that were analyzed with an Odyssey imaging system (LI-COR Biosciences, Nebraska) or by ECL Western blot Detection reagents (GE Healthcare).
MS analysis
In-gel digestion of purified glycosylated AcrA was carried out using trypsin (Sequencing Grade, Promega). Dried tryptic peptides were resuspended in 10 μL of 0.1% trifluoroacetic acid, desalted with a C18 ZipTip (Millipore, Bedford, MA), eluted with 60% acetonitrile, dried down and reconstituted in 8 μL of 0.1% trifluoroacetic acid. NanoLC-MS/MS analysis was performed using a hybrid quadrupole orthogonal acceleration time-of-flight mass spectrometer, Q-TOF Premier (Waters, Milford, MA), equipped with a nanoACQUITY Ultra performance liquid chromatography system (Waters) in the positive ion mode as previously described (Faridmoayer et al. 2008) . Spectra were analyzed using Mass-Lynx V4.1 (Waters) and manually screened for the presence of glycopeptides. For LC-MALDI-TOF/TOF analysis, peptides were eluted in HCCA matrix and spotted directly onto a metal MALDI target plate Bruker MTP AnchorChip 800μm-384. MALDI-TOF/TOF MS and tandem (MS/MS) spectra were acquired using a Bruker Ultraflex II mass spectrometer in the positive ion reflection mode. Spectra were analyzed using the FlexAnalysis software (Bruker Daltonics).
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Supplementary data for this article is available online at http:// glycob.oxfordjournals.org/.
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